Filing Details
- Accession Number:
- 0001179110-15-003674
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-27 16:45:41
- Reporting Period:
- 2015-02-25
- Filing Date:
- 2015-02-27
- Accepted Time:
- 2015-02-27 16:45:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1065087 | Albany Molecular Research Inc | AMRI | Services-Commercial Physical & Biological Research (8731) | 141742717 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1558521 | M Michael Nolan | 26 Corporate Circle Albany NY 12203 | Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-02-25 | 5,000 | $3.43 | 73,318 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-02-25 | 5,000 | $16.17 | 68,318 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option to Purchase Common Stock | Acquisiton | 2015-02-25 | 5,000 | $3.43 | 5,000 | $3.43 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
70,000 | 2022-09-17 | No | 4 | M | Direct |
Footnotes
- 50% of grant is time based and 50% is performance based. Time based grant vests 25% per year on each of the first 4 anniversaries of the date of grant (September 12, 2012). Performance based grant vests 25% per year on each of the first 4 anniversaries of the grant date if (1) certain performance criteria related to the Company's operating profitability are reached and (2) the grantee is employed on such anniversary date; if the foregoing criteria are not met on the anniversary date, 25% of the shares of options under the performance award will immediately be forfeited. The 5,000 shares being exercised represent a portion of the vested grant.